ii "The positive recommendation from NICE will allow patients with CLL in England and Wales to access this important new treatment option." In addition, on October 9, 2023, BRUKINSA received ...

Following the positive recommendation from INESSS issued in October 2022, VRAYLAR completed negotiations at pCPA and has an active letter of intent (LOI). Québec and the federal plans (NIHB, CSC and ...